MTOR and fleck corneal dystrophy: mTOR inhibition with rapamycin has shown therapeutic promise in FCD patients and animals models (Baek et al., 2015; Curatolo and Moavero, 2013; Lim et al., 2015; Moon et al., 2015); however, rapamycin treatments are not acute.